Target intelligence / Profile preview

RNA-binding motif protein 4B (RBM4B)

Target
RBM4B
Molecular classification
RNA-binding protein, Contains RNA recognition motif (RRM) domains, Contains CCHC-type zinc finger domains, Other (does not fit primary drug target classes such as receptor, enzyme, ion channel, etc.)
01

Overview

RNA-binding motif protein 4B (RBM4B) is a member of the RNA-binding protein family distinguished by its RNA recognition motifs and zinc finger domains, which facilitate its interaction with RNA molecules. It is mainly involved in the regulation of alternative splicing and translation of mRNAs, particularly in muscle cell differentiation, stress response, and circadian rhythm regulation. RBM4B is expressed in mammalian tissues, including the nervous system and pancreas, and may play a regulatory role in the alternative splicing of genes involved in glucose signaling and insulin sensitivity. Structurally, RBM4B consists of two N-terminal RNA recognition motifs (RRMs), a CCHC-type zinc finger, and a less conserved C-terminal domain important for nuclear localization and splicing function. Although described in cellular and disease processes, RBM4B is not considered a validated therapeutic target in current pharmacology, and no drugs are directed against it.

Other names
RBM4BRBM30MGC10871ZCCHC15RBM4LZCRB3BZCCHC21BRNA-binding motif protein 30RNA-binding protein 4BRNA-binding protein 30Zinc finger CCHC-type and RNA binding motif 3B
02

Mechanism of action

Not applicable (no approved drugs targeting RBM4B or mechanisms described)

03

Biological functions

Alternative splicing of pre-mRNATranslation regulationRegulation of exon selection (activator and repressor)Muscle cell differentiationCap-dependent and IRES-mediated translationAssociation with stress granules and microRNPsInteraction with microRNAs during muscle differentiationRegulation of stress response gene expression
04

Disease associations

Suggested roles in Down SyndromePossible involvement in Frontotemporal Dementia or Amyotrophic Lateral Sclerosis 7Potential implication in cancer biology and circadian rhythm disorders (based on general RNA-binding protein roles, not RBM4B-specific direct evidence)

Beyond the preview

Go deeper on RNA-binding motif protein 4B (RBM4B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA-binding motif protein 4B (RBM4B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call